Diagnosis of Skin Cancer

The diagnosis of skin cancer is a systematic and multi-stage process that requires the integration of clinical observation, imaging techniques, and laboratory analysis. Physicians typically begin with a visual examination, observing the shape, color, and size changes of skin lesions, and assessing risk factors based on the medical history. If abnormalities are found during the initial examination, further procedures such as biopsies or imaging studies may be conducted to determine the nature and extent of the lesions.

Early and accurate diagnosis is crucial for treatment effectiveness, significantly improving the success rate of treatment and patient prognosis. The diagnostic process must consider the characteristics of different types of skin cancer; for example, melanoma may require special pathological analysis, while the diagnosis of basal cell carcinoma may rely more on biopsy results. The medical team will choose the most appropriate diagnostic strategy based on the characteristics of the case and integrate various information to achieve an accurate diagnosis.

Clinical Evaluation

Clinical evaluation is the first step in diagnosing skin cancer, where physicians carefully observe the appearance characteristics of skin lesions through visual inspection. This includes analyzing the shape of the lesions (such as whether the borders are regular), color uniformity, diameter size, and whether symptoms like itching, pain, or bleeding are present. Physicians will also inquire about the patient's past sun exposure habits, family history, and the development history of the lesions.

During the visual examination, physicians may use the "ABCDE criteria" to assess malignant signs of skin lesions: A (Asymmetry), B (Border irregularity), C (Color variation), D (Diameter greater than 6 mm), E (Evolution of shape or color). This method is particularly useful for the initial screening of melanoma.

Medical Examinations and Procedures

Biopsy is a key step in confirming skin cancer. Depending on the location and size of the lesions, physicians may choose punch biopsy, excisional biopsy, or full-thickness excision. Pathologists will analyze the tissue samples under a microscope to assess cellular atypia, mitotic activity, and invasion depth to determine the type and stage of cancer.

Imaging examinations include ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI), which are used to assess tumor depth, lymph node metastasis, and the condition of distant organs. Positron emission tomography-computed tomography (PET-CT) helps determine whether cancer has spread to other parts of the body. Although blood tests cannot directly diagnose skin cancer, they can assess liver and kidney function, providing reference for subsequent treatment.

Screening and Assessment Tools

Self-screening is an important method for the early detection of skin cancer. Patients can perform a "head-to-toe" full-body examination, paying special attention to newly appearing moles or changes in the shape of existing moles. Medical institutions often use dermatoscopy for professional screening; this non-invasive tool magnifies the surface structures of lesions and skin layers, assisting physicians in identifying potential malignant signs.

Digital imaging systems such as "skin imaging analysis software" can track changes in lesions over time by comparing historical photos to assess the speed of changes. Risk assessment questionnaires are used to evaluate personal sun exposure history, family genetic tendencies, and immune system status, helping physicians determine the risk level of cases and establish screening frequency.

Differential Diagnosis

When diagnosing skin cancer, physicians must distinguish it from various benign skin lesions. For example, common moles may be confused with melanoma and require dermatoscopy to observe whether the pigment distribution is uniform. Seborrheic keratosis's rough patches may be misdiagnosed as squamous cell carcinoma, necessitating confirmation through biopsy.

Certain inflammatory skin diseases such as chronic eczema or psoriasis may present with red, swollen, and scaly symptoms that resemble early signs of skin cancer. Additionally, the shape and hardness of benign tumors like hemangiomas or lipomas may also lead to misdiagnosis, requiring imaging studies or histopathological analysis for exclusion.

The Importance of Early Diagnosis

Early detection can significantly enhance treatment success rates; for instance, if melanoma is treated at the in situ stage, the 5-year survival rate can exceed 98%. Conversely, if cancer has spread to lymph nodes, the complexity of treatment and mortality rates will increase significantly. Regular skin self-examinations and professional check-ups can help detect abnormal lesions early, preventing disease progression.

Early diagnosis can also narrow the scope of treatment, reducing the extent of surgical excision and the risk of complications. For example, if basal cell carcinoma is excised in the early stage, it usually allows for the preservation of more normal tissue. Furthermore, early treatment can prevent cancer from invading nerves or bones, decreasing the need for subsequent rehabilitation or reconstructive surgeries.

 

Frequently Asked Questions

What common medical examination methods are used for diagnosing skin cancer besides visual observation?

In addition to visual observation, common methods for diagnosing skin cancer include dermoscopy, which magnifies the surface structures of the skin; biopsy (tissue examination) to confirm the type and malignancy of cancer cells; and if cancer spread is suspected, imaging studies such as ultrasound or CT scans may be arranged to assess the depth of lesions and metastasis.

When self-examining for skin abnormalities, what characteristics of moles or spots should be particularly noted?

During self-examination, attention should be paid to the "ABCDE" principles: Asymmetry, Border irregularity, Color variation, Diameter greater than 6 mm, and Evolution of shape or size. If moles or spots exhibit itching, bleeding, or pain, medical attention should be sought immediately.

How does a history of sunburn affect the diagnosis of skin cancer?

Long-term exposure to ultraviolet rays (such as sunburn or prolonged sun exposure) increases the risk of skin cancer. During diagnosis, physicians will inquire in detail about the frequency and locations of sunburns. A history of sunburn can help physicians assess the likelihood of lesions and may suggest more frequent follow-up examinations, especially for patients with a history of severe sunburn.

What follow-up assessments are required for patients after a confirmed diagnosis of skin cancer?

Follow-up examinations after diagnosis typically include regular skin checks to monitor for new lesions, blood tests or imaging studies to assess the risk of metastasis, and developing a post-treatment follow-up plan based on the type of cancer. For example, melanoma patients may need full-body skin scans every 3-6 months.

Do individuals with a history of skin conditions like vitiligo need more frequent skin cancer screenings?

Yes. Patients with vitiligo have a weaker skin protective function and a higher risk of skin cancer, so it is recommended to undergo professional skin examinations every 6-12 months. Physicians may also recommend enhanced sun protection measures and closely monitor skin changes to detect potential lesions early.

Skin Cancer